G Medical Innovations Holdings Ltd. (GMVD): Price and Financial Metrics
GET POWR RATINGS... FREE!
GMVD Stock Price Chart Interactive Chart >
GMVD Price/Volume Stats
| Current price | $0.23 | 52-week high | $6.74 |
| Prev. close | $0.22 | 52-week low | $0.21 |
| Day low | $0.23 | Volume | 62,800 |
| Day high | $0.24 | Avg. volume | 1,761,552 |
| 50-day MA | $0.34 | Dividend yield | N/A |
| 200-day MA | $1.39 | Market Cap | N/A |
G Medical Innovations Holdings Ltd. (GMVD) Company Bio
G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel. The company's products include Prizma, a plug-and-play medical device that measures vital signs with electronic medical records functionality and clinical grade reporting standards; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiogram data continuously for up to 14 days. It also develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics. In addition, it offers monitoring services, including independent diagnostic testing facility monitoring and private monitoring services. G Medical Innovations Holdings Ltd was founded in 2014 and is based in Rehovot, Israel.
Latest GMVD News From Around the Web
Below are the latest news stories about G MEDICAL INNOVATIONS HOLDINGS LTD that investors may wish to consider to help them evaluate GMVD as an investment opportunity.
G Medical Innovations is introducing affordable, new direct to consumer home health testing kits with quick resultsThe first 7 new health testing kits covering Food sensitivity (96 and 208 types of food), indoor/outdoor allergies, Thyroid functioning, testosterone levels, HbA1C and HPV tests will be available for purchasing by consumers during Q3-2022 online as well as at popular retail locations and pharmacies The tests offered to the consumers utilize FDA registered componentsTest kit prices range from $50-$260, all provide results within days by CLIA certified labsAdditional testing kits to be announced l |
G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) Announces Receipt of Nasdaq Minimum Bid Price NotificationIrvine, California, June 17, 2022 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (Nasdaq: GMVD) (the “Company”), a telehealth, medical device, and remote patient monitoring company providing clinical-grade solutions for consumers, medical professionals, and healthcare institutions, has received a written notice (the “Notice”) from Nasdaq Stock Market LLC, indicating that the Company is not in compliance with the minimum bid price requirement for continued listing set forth in Nasdaq Lis |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on MondayGood morning, traders! |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on FridayGood morning, investors! |
G Medical Innovations Holdings Ltd. (NASDAQ: GMVD) Announces Share Repurchase ProgramIrvine, California, May 20, 2022 (GLOBE NEWSWIRE) -- G Medical Innovations Holdings Ltd. (NASDAQ: GMVD) (the “Company”) today announced that its board of directors has authorized a share repurchase program to acquire up to $1 million of the Company's ordinary shares (the “Repurchase Plan”). The Company may purchase ordinary shares from time to time in the open market, through privately negotiated transactions, or any other legally permissible ways, depending on market conditions, share price, tr |
GMVD Price Returns
| 1-mo | -34.38% |
| 3-mo | -65.46% |
| 6-mo | -81.60% |
| 1-year | -90.00% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -86.23% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
| 2017 | N/A |
Loading social stream, please wait...